Plebanek, Michael P.
Angeloni, Nicholas L.
Vinokour, Elena
Li, Jia
Henkin, Anna
Martinez-Marin, Dalia
Filleur, Stephanie
Bhowmick, Reshma
Henkin, Jack
Miller, Stephen D.
Ifergan, Igal
Lee, Yesung
Osman, Iman
Thaxton, C. Shad
Volpert, Olga V.
Article History
Received: 13 September 2016
Accepted: 18 September 2017
First Online: 6 November 2017
Competing interests
: O.V.V. and J.H. declare financial interest in Pamdeca LLC, a start-up biotechnology company, which develops PEDF peptide mimetics for cancer therapy. The remaining authors declare no competing financial interests.